Synthorx nabs $10 mln Series B

La Jolla, California-based Synthorx Inc, which uses synthetic biology to discover and develop new protein therapeutics, has closed $10 million in Series B financing. RA Capital Management led the round with participation from return backers Avalon Ventures and Correlation Ventures. Also, Dr. Andrew Levin, managing director at RA Capital, has been added to Synthorx’s board of directors.

Source: Press Release